GoodRx Care vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats GoodRx Care overall, scoring 7.7/10 vs 6.2/10. MEDVi is more affordable at $299/mo vs $318/mo. Choose GoodRx Care for goodrx users who want a convenient path to glp-1 prescriptio. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of GoodRx Care and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
GoodRx Care
#40 of 40GoodRx's telehealth offering for GLP-1 prescriptions, leveraging their massive prescription discount platform to help users find the lowest medication prices.
Visit GoodRx CareMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | GoodRx Care | MEDVi |
|---|---|---|
| Our Score | 6.2/10 | 7.7/10 |
| Starting Price | $318/mo | $299/mo |
| Medication Type | Brand | Compounded |
| Insurance Accepted | Yes | No |
| Best For | GoodRx users who want a convenient path to GLP-1 prescriptions with built-in discount tools | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #40 | #21 |
Pros & Cons Compared
GoodRx Care
Pros
- +Seamless integration with GoodRx discount tools — automatically finds the lowest pharmacy price for your prescription
- +Low $89 consultation fee with access to GoodRx Gold discounts for ongoing medication savings
- +Insurance accepted — GoodRx helps stack savings cards with insurance for maximum cost reduction
- +Familiar, trusted platform that millions already use for prescription discounts
Cons
- −Consultation-only model — GoodRx doesn't dispense medication directly, adding a step to the process
- −Limited clinical support — this is a prescribing service, not a comprehensive care program
- −Brand-name focus — compounded options are limited through GoodRx's pharmacy network
- −Follow-up care is basic compared to dedicated GLP-1 platforms
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out GoodRx Care with a score of 7.7/10 vs 6.2/10. If budget is your priority, MEDVi starts at $299/mo compared to GoodRx Care's $318/mo. GoodRx Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose GoodRx Care if you want: goodrx users who want a convenient path to glp-1 prescriptions with built-in discount tools. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.